The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome


Carlioglu A., Kaygusuz I., Karakurt F., Gumus I. I., Uysal A., KASAPOĞLU B., ...More

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.290, no.5, pp.929-935, 2014 (SCI-Expanded) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 290 Issue: 5
  • Publication Date: 2014
  • Doi Number: 10.1007/s00404-014-3275-8
  • Journal Name: ARCHIVES OF GYNECOLOGY AND OBSTETRICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.929-935
  • Keywords: Polycystic ovary syndrome, Platelet activating factor acetyl hydrolyze, Oxidized LDL, Paraoxonase1, Paraoxonase1 phenotypes, Arylesterase, CORONARY-ARTERY-DISEASE, ACETYLHYDROLASE PAF-AH, INTIMA-MEDIA THICKNESS, RISK-FACTOR, CARDIOVASCULAR-DISEASE, INSULIN-RESISTANCE, HEART-DISEASE, CHRONIC INFLAMMATION, PHOSPHOLIPASE A(2), OXIDATIVE STRESS
  • Lokman Hekim University Affiliated: No

Abstract

Purpose To evaluate the platelet activating factor acetyl hydrolyze (PAF-AH), oxidized low-density lipoprotein (ox-LDL), paraoxonase 1 (PON1), arylesterase (ARE) levels and the effects of metformin and Diane-35 (ethinyl oestradiol + cyproterone acetate) therapies on these parameters and to determine the PON1 polymorphisms among PCOS patients.